TW429241B - Nitrone derivatives - Google Patents
Nitrone derivativesInfo
- Publication number
- TW429241B TW429241B TW086113627A TW86113627A TW429241B TW 429241 B TW429241 B TW 429241B TW 086113627 A TW086113627 A TW 086113627A TW 86113627 A TW86113627 A TW 86113627A TW 429241 B TW429241 B TW 429241B
- Authority
- TW
- Taiwan
- Prior art keywords
- rings
- binded
- cycloalkane
- carbon atoms
- bicycloalkane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27754596 | 1996-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW429241B true TW429241B (en) | 2001-04-11 |
Family
ID=17585040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW086113627A TW429241B (en) | 1996-09-26 | 1997-09-19 | Nitrone derivatives |
Country Status (8)
Country | Link |
---|---|
US (1) | US6194461B1 (zh) |
EP (1) | EP0945426A4 (zh) |
KR (1) | KR20000048601A (zh) |
CN (1) | CN1238759A (zh) |
AU (1) | AU4222997A (zh) |
CA (1) | CA2265053A1 (zh) |
TW (1) | TW429241B (zh) |
WO (1) | WO1998013332A1 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL128070A0 (en) | 1996-07-19 | 1999-11-30 | Centaur Pharmaceuticals Inc | Furan nitrone compounds |
MA26553A1 (fr) * | 1997-10-17 | 2004-12-20 | Centaur Pharmaceuticals Inc | Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la |
ZA99255B (en) * | 1998-01-16 | 1999-07-14 | Centaur Pharmaceuticals Inc | Thiopene nitrone compounds. |
AU742768B2 (en) * | 1998-01-16 | 2002-01-10 | Renovis, Inc. | Thioether furan nitrone compounds |
US6730700B2 (en) | 1998-12-02 | 2004-05-04 | Renovis, Inc. | 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
UA66401C2 (en) * | 1998-12-02 | 2004-05-17 | Sentor Pharmaceuticals Inc | 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same |
AU2002253857A1 (en) | 2001-01-08 | 2002-09-04 | Centaur Pharmaceuticals, Inc. | Use of aryl nitrone compounds in methods for treating neuropathic pain |
US7115666B2 (en) * | 2002-10-15 | 2006-10-03 | Renovis, Inc. | Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
WO2005080359A1 (en) | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Benzamide derivatives and their use as glucokinae activating agents |
WO2006105215A2 (en) * | 2005-03-28 | 2006-10-05 | Acucela, Inc. | The use of a spin trap for enhancing retinal cell survival and treating retinal degenerative diseases |
CN101468970B (zh) * | 2008-04-25 | 2011-05-11 | 暨南大学 | 一种硝酮类化合物及其制备方法和在制药中的应用 |
FR3012460B1 (fr) | 2013-10-25 | 2015-12-11 | Michelin & Cie | Composition de caoutchouc comprenant un elastomere dienique portant des fonctions imidazole reparties de facon aleatoire le long de la chaine |
FR3012451B1 (fr) | 2013-10-25 | 2016-11-11 | Michelin & Cie | Compose 1,3-dipolaire portant une fonction imidazole |
FR3012458B1 (fr) | 2013-10-25 | 2015-10-30 | Michelin & Cie | Composition de caoutchouc comprenant un additif compose 1,3-dipolaire portant une fonction imidazole |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS49135962A (zh) | 1973-05-15 | 1974-12-27 | ||
DE69012138T2 (de) * | 1989-10-17 | 1995-04-06 | Oklahoma Med Res Found | Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten. |
ATE209908T1 (de) | 1991-06-18 | 2001-12-15 | Oklahoma Med Res Found | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN |
US5455272A (en) * | 1993-10-22 | 1995-10-03 | Oklahoma Medical Research Foundation | Spin trap nitronyl hindered phenols |
US5488145A (en) * | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
WO1997019054A1 (en) * | 1995-11-17 | 1997-05-29 | Florida International University | Azulenyl nitrone spin trapping agents, methods of making and using same |
JPH09278652A (ja) | 1996-04-05 | 1997-10-28 | Sumitomo Pharmaceut Co Ltd | 網膜疾患治療剤 |
IL128070A0 (en) * | 1996-07-19 | 1999-11-30 | Centaur Pharmaceuticals Inc | Furan nitrone compounds |
US6083989A (en) * | 1999-05-18 | 2000-07-04 | Centaur Pharmaceuticals, Inc. | Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
-
1997
- 1997-09-19 TW TW086113627A patent/TW429241B/zh not_active IP Right Cessation
- 1997-09-22 CN CN97180100A patent/CN1238759A/zh active Pending
- 1997-09-22 KR KR1019990702535A patent/KR20000048601A/ko not_active Application Discontinuation
- 1997-09-22 AU AU42229/97A patent/AU4222997A/en not_active Abandoned
- 1997-09-22 EP EP97940459A patent/EP0945426A4/en not_active Withdrawn
- 1997-09-22 US US09/254,856 patent/US6194461B1/en not_active Expired - Fee Related
- 1997-09-22 WO PCT/JP1997/003377 patent/WO1998013332A1/ja not_active Application Discontinuation
- 1997-09-22 CA CA002265053A patent/CA2265053A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20000048601A (ko) | 2000-07-25 |
US6194461B1 (en) | 2001-02-27 |
EP0945426A4 (en) | 2003-01-15 |
CN1238759A (zh) | 1999-12-15 |
WO1998013332A1 (fr) | 1998-04-02 |
CA2265053A1 (en) | 1998-04-02 |
AU4222997A (en) | 1998-04-17 |
EP0945426A1 (en) | 1999-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW429241B (en) | Nitrone derivatives | |
YU97292A (sh) | N-fenilalanil i n-fenilglicil derivati dipeptida l-azetidin-2-karboksilne kiseline | |
ES2126068T3 (es) | Derivados de estilbeno citotoxicos y composicion farmaceutica que los contiene. | |
MX9603506A (es) | Compuestos oxazol aromaticos, heterociclicos y sus usos. | |
SE9103572D0 (sv) | Organic salts of n,n'-diacetyl cystine | |
AU6601294A (en) | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | |
CA2316902A1 (en) | Alpha-aminoamide derivatives useful as analgesic agents | |
DE69221721D1 (de) | Ethanolaminderivate mit anti-pollakiurawirkung | |
EP0712844A4 (en) | NOVEL CARBOXYLIC ACID COMPOUND WITH FUSED CORE OR SALT THEREOF, AND ITS USE IN MEDICINE | |
NZ333926A (en) | Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use | |
NZ260159A (en) | N-bicyclic nitrogen compounds and medicaments | |
NZ334848A (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases caused by fungi and bacteria | |
WO1995001170A3 (en) | Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders | |
WO1999004770A3 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
WO2002094770A3 (en) | Aminoalcohol derivatives | |
KR970002634B1 (en) | Aminobenzoic acid derivatives | |
AU676348B2 (en) | New 2(1H)-quinolone compounds, process for their preparationand the pharmaceutical compositions which contain them | |
MX9709465A (es) | Derivados de bencimidazol 2-sustituidos como inhibidores de la proliferacion de celulas del musculo liso. | |
IL112344A (en) | Pharmaceutical compositions comprising 7, 9, 9-trisubstituted- 3-benzoyl-3, 7-diazabicyclo £3.3.1| nonanes for the treatment of cardiac arrhythmias | |
TW282470B (zh) | ||
BG101996A (en) | 9-n-ethylenederivatives of 9(s)-erythromycylamine | |
PT728002E (pt) | Utilizacao de derivados de 2-amino purina para o tratamento e profilaxia da infeccao pelo virus de herpes 7 humano | |
AU674955B2 (en) | Dopamine reincorporation inhibitor | |
TW343973B (en) | Morphinan derivative and medical use | |
ECSP972209A (es) | Nuevos compuestos, procedimientos para su preparacion, composiciones, farmaceuticas y su uso en terapia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent | ||
MM4A | Annulment or lapse of patent due to non-payment of fees |